This aspect is especially valuable for individuals at risk of or currently facing neurodegenerative diseases like Alzheimers and Parkinsons
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read DSIP Peptide: Benefits, Uses, Side Effects, Dosage, and Research
(ii) As a delayed regimen, the therapy (BPC 157 or saline (5 mL/kg)) was given as an intragastric administration at 4.30 h of ligation time for assessment at 5 h of ligation time, or BPC 157 as an oral administration, given continuously in drinking water from 5 h of ligation time until the sacrifice at 24 h of ligation time (0.16 g/mL/rat, 0.16 ng/mL/rat) while controls received drinking water only (12 mL/day/rat)
Is heparin treatment the optimal management for cerebral venous thrombosis